Finance

Lists
300705:SHE
Hunan Jiudian Pharmaceutical Co Ltd
CNÂ¥11.15
+1.09%
(+0.12) 1D
Sep 8, 3:04:37 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300705...
Open
CNÂ¥11.00
High
CNÂ¥11.18
Low
CNÂ¥10.98
Mkt. cap
5.52B
Avg. vol.
12.29M
Volume
4.79M
Dividend
3.59%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 28, 2026
P/E ratio
13.51
52-wk high
CNÂ¥18.33
52-wk low
CNÂ¥9.26
EPS
CNÂ¥0.83
Shares outstanding
500.29M
No. of employees
2K
Open
CNÂ¥11.00
High
CNÂ¥11.18
Low
CNÂ¥10.98
Mkt. cap
5.52B
Avg. vol.
12.29M
Volume
4.79M
Dividend
3.59%
Quarterly dividend
CNÂ¥0.10
Ex-dividend date
May 28, 2026
P/E ratio
13.51
52-wk high
CNÂ¥18.33
52-wk low
CNÂ¥9.26
EPS
CNÂ¥0.83
Shares outstanding
500.29M
No. of employees
2K
About Hunan Jiudian Pharmaceutical Co Ltd
CEO-
Employees2.3K
FoundedJan 19, 2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
756.09M
842.86M
595.24M
691.60M
Cost of goods sold
191.30M
270.16M
197.35M
262.54M
Cost of revenue
191.30M
270.16M
197.35M
262.54M
Research and development expenses
49.31M
44.26M
34.19M
43.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
382.02M
423.63M
294.96M
257.92M
Operating expense
414.63M
499.23M
327.97M
300.80M
Total operating expenses
605.93M
769.40M
525.32M
563.34M
Operating income
150.15M
73.47M
69.92M
128.25M
Other non operating income
-6.21M
-17.50M
-200.62K
-15.65M
EBT including unusual items
127.10M
73.68M
61.03M
118.61M
EBT excluding unusual items
140.17M
51.82M
63.36M
118.97M
Income tax expense
12.16M
10.01M
6.77M
17.76M
Effective tax rate
9.57%
13.58%
11.09%
14.97%
Other operating expenses
-16.11M
30.68M
-1.15M
-156.22K
Net income
114.94M
66.46M
56.74M
102.93M
Net profit margin
15.20%
7.88%
9.53%
14.88%
Earnings per share
-
-
-
-
Interest and investment income
296.23K
474.72K
270.58K
6.64M
Interest expense
-3.95M
-4.56M
-6.64M
-270.58K
Net interest expenses
-3.65M
-4.09M
-6.37M
6.37M
Depreciation and amortization charges
-
-
-
-
EBITDA
173.22M
103.59M
100.05M
172.68M
Gain or loss from assets sale
-
-50.73K
-
57.60K
AI content may include mistakes. Learn more
Google apps